Table 2.
Toxicities
| |
No. of Patients (%) |
|
||
|---|---|---|---|---|
| Grade 1 | Grade 2 | Grade 3 | Grade 4 | |
|
Hematologic event |
|
|
|
|
| Neutropenia |
2 (7.4) |
3 (11.1) |
2 (7.4) |
0 (0.0) |
| Febrile neutropenia |
- |
- |
0 (0.0) |
0 (0.0) |
| Thrombocytopenia |
12 (44.4) |
1 (3.7) |
3 (11.1) |
0 (0.0) |
| Anemia |
10 (37.0) |
5 (18.5) |
2 (7.4) |
0 (0.0) |
|
Nonhematologic event |
|
|
|
|
| Asthenia |
7 (25.9) |
11 (40.7) |
4 (14.8) |
0 (0.0) |
| Nausea/Vomiting |
10 (37.0) |
6 (22.2) |
0 (0.0) |
0 (0.0) |
| Mucitis |
3 (11.1) |
0 (0.0) |
0 (0.0) |
0 (0.0) |
| Diarrhea |
6 (22.2) |
4 (14.8) |
0 (0.0) |
0 (0.0) |
| Sensory neuropathy | 10 (37.0) | 2 (7.4) | 2 (7.4) | 0 (0.0) |
Toxicities were evaluated according to National Cancer Institute Common Terminology Criteria for Adverse Events (version 3.0).